Luo, Zhiguo
493  results:
Search for persons X
?
1

Clinical features and prognosis of patients with metastatic..:

Liu, Xin ; Yue, Han ; Jiang, Shiyu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469730/.  , 2023
 
?
2

First-in-human phase I dose-escalation and dose-expansion t..:

Wang, Xuan ; Luo, Zhiguo ; Chen, Jing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814429/.  , 2023
 
?
3

Comparative analysis of adjuvant therapy for stage III BRAF..:

Zhong, Jingqin ; Sun, Wei ; Hu, Tu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242313/.  , 2023
 
?
4

Safety and efficacy of Pucotenlimab (HX008) - a humanized i..:

Cui, Chuanliang ; Chen, Yu ; Luo, Zhiguo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901108/.  , 2023
 
?
5

Survival impact of immediate complete lymph node dissection..:

Zhong, Jingqin ; Zou, Zijian ; Hu, Tu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618307/.  , 2023
 
?
6

Case Report: Clinical response to anaplastic lymphoma kinas..:

Zhao, Ting ; Zhang, Xiaowei ; Liu, Xin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076585/.  , 2023
 
?
7

Pan-cancer analysis identified OAS1 as a potential prognost..:

Jiang, Shan ; Deng, Xinzhou ; Luo, Ming...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511872/.  , 2023
 
?
8

A real‐world study of adjuvant anti‐PD ‐1 immunotherapy on ..:

Sun, Wei ; Xu, Yu ; Yan, WangJun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469738/.  , 2023
 
?
9

Sintilimab versus placebo in combination with chemotherapy ..:

Lu, Zhihao ; Wang, Junye ; Shu, Yongqian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016493/.  , 2022
 
?
10

Head-to-head evaluation of [(18)F]FDG and [(68) Ga]Ga-DOTA-..:

Gu, Bingxin ; Liu, Xin ; Wang, Shuoer...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206606/.  , 2022
 
?
11

Case Report: Molecular Profiling Assists in the Diagnosis a..:

Yu, Bo ; Wang, Qifeng ; Liu, Xin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005951/.  , 2022
 
?
12

Clinical value of sentinel lymph node biopsy in patients wi..:

ZOU Zijian ; SUN Wei ; HU Tu...
http://www.china-oncology.com/fileup/1007-3639/PDF/1675314917012-784720088.pdf.  , 2022
 
?
13

COVID-19 and systemic anti-cancer therapy:

HU Xichun ; HU Zhihuang ; WANG Biyun...
http://www.china-oncology.com/fileup/1007-3639/PDF/1658380581026-583865009.pdf.  , 2022
 
?
 
?
15

Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therap..:

Li, Tong ; Xu, Yu ; Sun, Wei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867270/.  , 2022
 
1-15